News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|February 7, 2025

Successful Implementation of Bispecific Therapies: Expert Recommendations

Author(s)Ryan Haumschild, PharmD, MS, MBA, CPEL, John Allan, MD, Tara Graff, MD

Panelists discuss best practices for successfully implementing a bispecifics program and overcoming logistical challenges.

Episodes in this series

EP. 1 ASH 2024 Updates on Bispecific Therapies in B-Cell Lymphomas

EP. 1 ASH 2024 Updates on Bispecific Therapies in B-Cell Lymphomas

EP. 2 Emerging Data for Odronextamab in DLBCL

EP. 2 Emerging Data for Odronextamab in DLBCL

EP. 3 Sequencing Consequences for Earlier Line Use of Bispecifics in B-Cell Lymphomas

EP. 3 Sequencing Consequences for Earlier Line Use of Bispecifics in B-Cell Lymphomas

EP. 4 Exploring Bispecifics in Earlier Lines of Therapy for B-Cell Lymphomas

EP. 4 Exploring Bispecifics in Earlier Lines of Therapy for B-Cell Lymphomas

EP. 5 ASH 2024 Highlights: Bispecifics in Combination Therapies for B-Cell Lymphomas

EP. 5 ASH 2024 Highlights: Bispecifics in Combination Therapies for B-Cell Lymphomas

EP. 6 MAIC Analyses and Bispecific Therapies: Guiding Treatment Decisions in B-Cell Lymphomas

EP. 6 MAIC Analyses and Bispecific Therapies: Guiding Treatment Decisions in B-Cell Lymphomas

EP. 7 Understanding CRS and ICANS: Real-World Incidence and Key Patient Risk Factors

EP. 7 Understanding CRS and ICANS: Real-World Incidence and Key Patient Risk Factors

EP. 8 Key Strategies for Preventing CRS and ICANS

EP. 8 Key Strategies for Preventing CRS and ICANS

EP. 9 Step-Up Dosing Protocols and Infection Prevention Strategies for Bispecifics in B-Cell Lymphomas

EP. 9 Step-Up Dosing Protocols and Infection Prevention Strategies for Bispecifics in B-Cell Lymphomas

EP. 10 Overcoming Logistical Hurdles in Bispecific Therapy Implementation

EP. 10 Overcoming Logistical Hurdles in Bispecific Therapy Implementation

EP. 11 Successful Implementation of Bispecific Therapies: Expert Recommendations

EP. 11 Successful Implementation of Bispecific Therapies: Expert Recommendations

EP. 12 Benefits of Implementing Bispecific Therapies in the Community

EP. 12 Benefits of Implementing Bispecific Therapies in the Community

EP. 13 Bridging the Gap: Enhancing Communication on Bispecifics Between Academic and Community Centers

EP. 13 Bridging the Gap: Enhancing Communication on Bispecifics Between Academic and Community Centers

EP. 14 Final Thoughts on Bispecifics in B-Cell Lymphomas From ASH 2024

EP. 14 Final Thoughts on Bispecifics in B-Cell Lymphomas From ASH 2024

Video content above is prompted by the following:

What best practices can you share for successfully implementing a bispecifics program and overcoming these challenges? (Ms Chang)

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Future Directions and Unmet Needs in HER2+ Breast Cancer Therapy

ByTiffany Traina, MD, FASCO,Mark Pegram, MD,Sherry Shen, MD,Jules Cohen, MD,Rochelle Horadam, RPh, BCOP

February 4th 2026

Additional Emerging HER2-Targeted Therapies in NSCLC

ByRyan Haumschild, PharmD, MS, MBA, CPEL,Joshua K. Sabari, MD,Jingxiao Jin, MD,Fred Hirsch, MD, PhD

February 4th 2026

Opportunities for Positioning TKIs as First-Line Therapy in HER2-Mutant NSCLC

ByRyan Haumschild, PharmD, MS, MBA, CPEL,Joshua K. Sabari, MD,Jingxiao Jin, MD,Fred Hirsch, MD, PhD

February 4th 2026

Addressing Care Coordination and Financial Toxicity in HER2+ Breast Cancer

ByTiffany Traina, MD, FASCO,Mark Pegram, MD,Sherry Shen, MD,Jules Cohen, MD,Rochelle Horadam, RPh, BCOP

February 4th 2026

5 experts are featured in this series

Safety Considerations and Practical Strategies for Using Bispecific Antibodies in Multiple Myeloma

ByZahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA ,Brooke Adams, PharmD, BCOP,Thomas Martin, MD,Raymond Thertulien, MD, PhD,Laura Joiner, PharmD, BCOP

February 3rd 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text